Viatris
VTRS· Manufacturing· Fiscal year ends in December
Scott A. Smith is the CEO of Viatris and was paid $15.3M in FY2025 (Dec), up 3%.
Executives5
See all- 1Scott A. SmithChief Executive OfficerFY2025
- 2Corinne Le GoffChief Commercial OfficerFY2025
- 3Doretta MistrasChief Financial OfficerFY2025
- 4Brian RomanFormer Chief Legal OfficerFY2025
- 5Andrew EnriettiChief Administrative and Transformation OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allViatris paid its 5 named executives $35.9M in total in FY2025 (Dec). CEO Scott A. Smith was paid $15.3M of that.
| Name | |||
|---|---|---|---|
| Scott A. SmithChief Executive Officer | Not disclosed | ||
| Corinne Le GoffChief Commercial Officer | Not disclosed | ||
| Doretta MistrasChief Financial Officer | Not disclosed | ||
| Brian RomanFormer Chief Legal Officer | Not disclosed | ||
| Andrew EnriettiChief Administrative and Transformation Officer | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers15
See allThe FY2025 (Dec) proxy of Viatris names 15 peer companies for pay. Among Viatris and these peers, CEO pay was 7th highest of 8 and total shareholder return was 7th highest of 8.
7th highest of 8in Viatris and its pay peers, FY2025 (Dec) by CEO pay:
7th highest of 8in Viatris and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board3
See all- Melina HigginsChair · 4 yr on the boardIndependentExecutive (Chair), Finance (Chair)—Paid as an executive
- Frank D’AmelioDirector · -1 yr on the boardIndependentFinance—Paid as an executive
- Michael SeverinoDirector · -1 yr on the boardIndependentScience and Technology—Paid as an executive
The board of the latest proxy (FY2024).
Activity
Filings22
See all| Current report | 8-K | May 15, 2026 | — |
| Current report | 8-K | May 4, 2026 | — |
| Proxy statement | DEF 14A | Apr 2, 2026 | FY2025 |
| Annual report | 10-K | Feb 26, 2026 | FY2025 |
| Current report | 8-K | Feb 3, 2026 | — |
| Current report | 8-K | Dec 5, 2025 | — |
